Christopher P. Lowe, Director at Vincerx Pharma, Inc. (VINC), bought 30,000 shares at $1.65 ($50K) on 2022-08-24, disclosed to the SEC on 2022-08-26.
Open-market purchase of $50k VINC by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.65 | 18,400 | $30K | 61.3% |
| 2 | $1.65 | 11,600 | $19K | 38.7% |
| Total | $1.65 avg | 30,000 | $50K | 100% |
| Filing → |
| CRTX | SELL | 2021-06-30 | $2.2M | — | Filing → |
| VINC | BUY | 2021-06-30 | $126K | — | Filing → |
| HNSN | BUY | 2014-05-20 | $29K | — | Filing → |